baber/WOPTO huggingface dataset:
Patent AU-2004219820-B2 (AU)
Title: Marker for detecting mesenchymal stem cell and method of distinguishing mesenchymal stem cell using the marker
Inventor: KATO YUKIO
IPC: G01N37/00
Filed: 2004-02-27
Granted: 2008-06-12
Abstract: The present invention provides a marker for detecting, separating/distinguishing a mesenchymal stem cell and a method for detecting, separating/distinguishing a mesenchymal stem cell by using the marker. A gene shown in the sequence listing is expressed specifically in a mesenchymal stem cell. The present invention comprises use of the gene as a marker for detecting mesenchymal stem cells. In addition, the present invention comprises a probe for detecting the mesenchymal stem cell marker gene and a PCR primer for amplifying the gene in a test cell in detecting the mesenchymal stem cell gene marker, and further comprises a polypeptide marker for detecting mesenchymal stem cells comprising a polypeptide wherein the mesenchymal stem cell marker gene of the present invention is expressed, an antibody for detecting the polypeptide marker which specifically binds to the polypeptide marker, and still further, a method for distinguishing and separating a mesenchymal stem cell by using a probe for detecting the mesenchymal stem cell marker gene, and an antibody which specifically binds to a polypeptide marker.
Patent AU-2004287879-B2 (AU)
Title: Antagonist anti-CD40 monoclonal antibodies and methods for their use
Inventor: LUQMAN MOHAMMAD
IPC: A61K38/20
Filed: 2004-11-04
Granted: 2011-01-06
Abstract: Methods of treating a subject for a cancer comprising neoplastic cells expressing the CD40 cell surface antigen are provided. The methods comprise combination therapy with interleukin-2 (IL-2) or biologically active variant thereof and at least one antagonist anti-CD40 antibody or antigen-binding fragment thereof. In some embodiments, these two therapeutic agents are concurrently administered as two separate pharmaceutical compositions, one containing IL-2 or biologically active variant thereof, which is administered according to a constant IL-2 dosing regimen or a two-level IL-2 dosing regimen, the other containing the antagonist anti-CD40 antibody or suitable antigen binding fragment thereof, which is administered according to a weekly dosing regimen, or alternatively is dosed once every two, three, or four weeks.; Administering of these two agents together potentiates their effectiveness in promoting a positive therapeutic response. The methods find use in treating CD40-expressing cancers, including B-cell related cancers and solid tumors.
Patent AU-2004288994-B2 (AU)
Title: Polar silanes for binding to substrates and use of the bound substrates in chromatography
Inventor: BORDUNOV ANDREI V
IPC: B01J20/287
Filed: 2004-10-04
Granted: 2011-07-14
Abstract: Polyfunctional silicon compounds having one of the following structures: wherein at least one of R,R and R is a leaving group which, after leaving, permits the Si in one of said structures to form a Si-O-Si or Si-O-Zr bond, wherein L, L and L comprise alkyl or substituted alkyl chains from 1 to 100 in length, wherein m = 1-100; wherein N - PG, N - PG and N - PG are nitrogen-containing polar groups; wherein each of E, E, and E comprise alkyl, substituted alkyl, aryl, or substituted aryl groups, comprising 1-50 carbon atoms, and exclude functional groups selected from the group consisting of hydroxyl, carboxyl, amino, thio, halo and sulfonate moieties. Also, such compounds bound to substrates for use as chromatography.packing.
Patent AU-2005219545-B2 (AU)
Title: Novel insecticides
Inventor: RENOLD PETER
IPC: C07D401/04
Filed: 2005-03-02
Granted: 2011-09-01
Abstract: Compounds of the formula (I), according to claim 1 and, where appropriate, tautomers thereof, in each case in free form or in salt form, can be used as agrochemical active ingredients and can be prepared in a manner known per se.
Patent AU-2005224486-B2 (AU)
Title: Sequence capable of accelerating gene expression at moderately low temperature
Inventor: FUJITA JUN
IPC: C12N15/09
Filed: 2005-03-01
Granted: 2008-12-04
Abstract: It is an object of the present invention to provide a method for increasing protein yield in recombinant DNA method using mammalian cell. When a mild low temperature transcription control element comprising at least one nucleotide sequence:  
x 1 ccccX 6 X 7 X 8   
wherein x 1  represents t, g, or a; x 6  represents g, a, or c; x 7  represents c, a or t; x 8  represents c, a or t, or a nucleotide sequence complementary to the nucleotide sequence is used as an enhancer and mammalian cells are cultivated at a mild low temperature, the transcription of a desired protein is accelerated.  When mild low temperature translation control element of SEQ ID NO: 23 is placed 5' to a coding sequence and 3' to a promoter, and mammalian cells are cultivated at a mild low temperature, the translation of a desired protein is accelerated.
Patent AU-2006205108-B2 (AU)
Title: Method and device for decreasing contamination
Inventor: BRANDE MATTHEW FREDERICK
IPC: G01N15/02
Filed: 2006-01-10
Granted: 2013-01-10
Abstract: Methods and devices to determine rate of particle production and the size range for the particles produced for an individual are described herein. The device (10) contains a mouthpiece (12) , a filter (14) , a low resistance one-way valve (16) , a particle counter (20) and a computer (30) . Optionally, the device also contains a gas flow meter (22) . The data obtained using the device can be used to determine if a formulation for reducing particle exhalation should be administered to an individual. This device is particularly useful prior to and/or following entry in a cleanroom to ensure that the cleanroom standards are maintained.
Patent AU-2006224690-B2 (AU)
Title: Sublingual coated tablet
Inventor: CATHERINE HERRY
IPC: A61K9/28
Filed: 2006-03-20
Granted: 2011-09-29
Abstract: The present invention relates to a sublingual coated tablet and to the method for the preparation thereof . The tablet comprises a core devoid of a pharmaceutically active substance, and a coating comprising at least one active substance. The preferred active substance in an opioid analgesic.
Patent AU-2006226334-B2 (AU)
Title: Heat accumulation segment
Inventor: KHANIN ALEXANDER
IPC: F01D25/24
Filed: 2006-03-21
Granted: 2009-09-10
Abstract: A heat accumulation segment for local separation of a flow duct inside a turbo engine, from a stator housing that radially surrounds the flow duct is provided. The heat accumulation segment includes two axially opposed joining contoured elements that are engageable with two components that are axially adjacent along the flow duct. A first one of the two joining contoured elements has a radially oriented recess with a frustoconical contoured surface against which a securing pin having a frustoconical external contour that acts radially under force action from a component that adjoins the first joining contoured element, and the first joining contoured element has a collar portion having a radially upper collar surface and a radially lower collar surface. The collar portion is connected within a counter-contoured receiving contoured element in the axially adjacent component by a joining force that acts between the securing pin and the frustoconical contoured surface.
Patent AU-2006230799-B2 (AU)
Title: Magnesium alloy
Inventor: JOYCE BETTLES COLLEEN
IPC: C22C23/06
Filed: 2006-04-04
Granted: 2011-07-07
Abstract: A magnesium-based alloy consists of 1.5-4.0% by weight rare earth element(s), 0.3-0.8% by weight zinc, 0.02-0.1% by weight aluminium, and 4-25 ppm beryllium. The alloy optionally contains up to 0.2% by weight zirconium, 0.3% by weight manganese, 0.5% by weight yttrium and 0.1% by weight calcium. The remainder of the alloy is magnesium except for incidental impurities.
Patent AU-2006232287-B2 (AU)
Title: Methods for producing polypeptides by regulating polypeptide association
Inventor: TOMOYUKI IGAWA
IPC: C12N15/09
Filed: 2006-03-31
Granted: 2011-10-06
Abstract: It is found that the assembly of polypeptides can be inhibited by altering an amino acid residue that forms the interface between the polypeptides in the assembly into another amino acid residue having the same charge as that of the amino acid residue. Thus, it becomes possible to form a hetero molecule with good efficiency. The present process can be suitably used, for example, in the production of a bispecific antibody.
Patent AU-2006243357-B2 (AU)
Title: Novel method for preventing or treating M tuberculosis infection
Inventor: LOBET YVES
IPC: A61K39/04
Filed: 2006-04-27
Granted: 2012-03-15
Abstract: The present invention is directed to methods of preventing reactivation of active and latent M. tuberculosis infections by administering a pharmaceutical composition comprising a nucleic acid encoding a Mtb72f fusion protein, or a Mtb72f fusion protein or an immunogenic fragment thereof, for example together with an adjuvant. The Mtb72f nucleic acid or fusion protein can be administered with one or more chemotherapeutic agents effective against a M. tuberculosis infection. The methods also provide for shortening the time course of a chemotherapeutic regimen against a M. tuberculosis infection.
Patent AU-2006243827-B2 (AU)
Title: An array of progressive ophthalmic lens elements
Inventor: VARNAS SAULIUS RAYMOND
IPC: G02C7/02
Filed: 2006-05-05
Granted: 2012-01-19
Abstract: An array of progressive ophthalmic lens elements is disclosed. The progressive ophthalmic elements contained in the array having substantially the same addition power and substantially the same optical prescription for distance vision. Each of the progressive ophthalmic lens elements has a progressive lens design characterised by a set of parameters defining a distance zone providing a refracting power for distance vision, a near zone providing a refracting power for near vision and a corridor having a refracting power varying from that of the distance zone to that of the near zone. The progressive ophthalmic lens elements provide, for a range of values or categories of at least two lifestyle and/or biometric parameters of lens wearers, different progressive lens designs in which at least two of the lens design parameters each have a respective value or characteristic attributable to, or associated with, a particular value or category of a respective one of the lifestyle and/or biometric parameters.
Patent AU-2006249581-B2 (AU)
Title: Improved main tee connection
Inventor: COYNE DANIEL J
IPC: E04B9/00
Filed: 2006-04-20
Granted: 2012-01-19
Abstract: A main tee with separate clips affixed on its ends for splicing the tee with identical tees in end-to-end butt joints. The tee and clip form a pocket for receiving the projecting end of an opposing clip with a uniform low insertion force. The clip is self-aligning with the pocket and when interconnected the clips precisely align the coupled tees both vertically and horizontally. The clips, formed of relatively strong material, have mutually engageable locking surfaces that ensure a strong joint.
Patent AU-2006262045-B2 (AU)
Title: System and method for high performance enterprise data protection
Inventor: CHI-HSIUNG LIU PETER
IPC: G06F11/00
Filed: 2006-06-23
Granted: 2011-11-03
Abstract: High performance, enterprise-level data protection system and method provides efficient block-level incremental snapshots of primary storage devices, and instant availability of such snapshots in immediately mountable form that can be directly used in place of the primary storage device. Related systems and applications are described, including an "Enterprise Image Destination" (EID) for backup images; a mirroring technique whereby a replacement physical primary facility may be created while working with a second storage unit as the primary source file system; and a technique for eliminating redundant data in backup images when multiple systems with partially common contents (e.g., operating system files, common databases, application executables, etc.) are being backed up. A number of examples showing "Fast Application Restore" (FAR) with the use of the invention are also provided.
Patent AU-2007200705-B2 (AU)
Title: Nutating pump with reduced pulsations in output flow
Inventor: HOGAN TIM PATRICK
IPC: F04B15/02
Filed: 2007-02-15
Granted: 2012-06-14
Abstract: [0086] A nutating pump is disclosed which has a modified piston and housing 01 casing that provides two distinct pump chambers or areas. Output fi om the fi st pump chamber is delivered during a first half of the dispense cycle or the piston movement cycle. A substantial portion of this output is held for delivery by the second chamber dining a second part or half of the dispense cycle. Thus, the output generated by the pump is not altered or reduced, it is delivered over the entire piston movement cycle as opposed to prior art pumps which deliver all of the fluid dining a first half or first portion of the piston movement cycle In this way, superior pulse modification is achieved as fluid is delivered across the entire piston movement cycle as opposed to a first half o first portion of the piston movement cycle. In additional embodiments disclosed, two distinct chambers are also provided but each chamber generates its own output as the piston includes two machined or flat sections for active pumping. Thus, each chamber generates its own positive output flow but the flow from each chamber is delivered during a different half of the piston movement cycle Thus, the flow is still distributed throughout the entire piston movement cycle: In the first embodiment with a fust and second chamber, the second chamber essentially acts as a holding station for fluid to be delivered during a second half of the piston movement cycle. Page 5 of i7 ~e
Patent AU-2007224229-B2 (AU)
Title: Dosage forms for administering combinations of drugs
Inventor: PLACHETKA JOHN R
IPC: A61K9/48
Filed: 2007-03-02
Granted: 2012-10-11
Abstract: The present invention is directed to dosage forms that can be used in therapeutic methods involving the oral co-administration of a combination of at least two drugs, one of which impairs gastrointestinal absorption and one of which does not. The dosage forms are designed so that the drug impairing absorption is not released into the gastrointestinal tract of a patient until after the drugs that do not impair absorption have been released and substantially absorbed. The invention may be used in treatment of migraine using a combination of triptans and NSAlDs or in the treatment of pain using a combination of NSAIDs and opioid analgesics.
Patent AU-2007234145-B2 (AU)
Title: Calibration method and calibration apparatus for a hand-held locating device
Inventor: SIMON BRANSON
IPC: G01V13/00
Filed: 2007-01-24
Granted: 2011-10-13
Abstract: A calibration apparatus for a hand-held locating device (7) has at least one first coil configuration (1a) having a first measuring range (2') and a second coil configuration (1a') having a second measuring range (2a'), in which measuring ranges (2a, 2a') homogeneous alternating magnetic fields can be generated in a specifiable ratio with respect to the strength of the magnetic fields. The coil configurations (1a, 1a') are arranged a specifiable distance apart so that the magnetic fields can be detected simultaneously by means of at least two aerials of the locating device (7) which are arranged at a fixed distance. The specifiable ratios define true distance parameters.
Patent AU-2007271465-B2 (AU)
Title: Method for retarding the setting of mortar and concrete surfaces
Inventor: VINCENT DANY
IPC: C09D5/00
Filed: 2007-07-02
Granted: 2012-07-19
Abstract: An exemplary method for set retarding the surface of a mortar or concrete material, comprising applying to the surface of a mortar or concrete, or to the inner surface of a mold for forming the mortar or concrete, a hot melt coating composition which is heated to assume a flowable or sprayable form, and allowing the hot melt coating composition to cool to ambient temperature whereby the composition forms a solidified membrane, and thereafter removing the membrane. Preferably, the hot melt coating composition contains at least one agent operative to retard the setting of the mortar or concrete, and optional finely divided particulate materials, light-reflective pigments, or mixtures thereof.
Patent AU-2007304996-B2 (AU)
Title: Self-preserved aqueous pharmaceutical compositions
Inventor: CHOWHAN MASOOD A
IPC: A61K47/10
Filed: 2007-09-20
Granted: 2013-03-21
Abstract: The use of a borate/polyol and zinc system to enhance the antimicrobial activity of multi-dose pharmaceutical compositions is described. The compositions do not require a conventional anti-microbial preservative and therefore are referred to as being 'self-preserved'. The compositions possess sufficient antimicrobial activity to satisfy the preservative efficacy requirements of the USP for aqueous ophthalmic compositions.
Patent AU-2007314678-B2 (AU)
Title: Surgical drape having highly flexible edge and a stiffening edge layer
Inventor: JOHANSSON HELENA
IPC: A61B19/08
Filed: 2007-10-24
Granted: 2013-03-21
Abstract: The present invention relates to a surgical drape (1) comprising one or more material layers (2-4). According to the invention, at least one edge area of the surgical drape (1) is formed by a single layer (5) of plastic film which, on one side, has an adhesive coating (6) and, on the side facing away from the adhesive coating (6), has a strip (7) of stiffening material releasably attached thereto.
Patent AU-2008229413-B2 (AU)
Title: Male coupling for connecting to female threaded coupling
Inventor: VOGEL TODD J
IPC: F16L17/00
Filed: 2008-03-17
Granted: 2013-06-27
Abstract: In one embodiment, a male coupling connectable to and separable from a female coupling (e.g., a female threaded port) is provided. The female coupling includes a receiving portion sized to receive at least a portion of the male coupling, where the receiving portion has internal threads provided therein. The male coupling includes a body having a passageway extending therethrough and a locking member disposed about the body and configured to move between locking and releasing positions. The locking member includes a retaining formation configured to engage the internal threads of the female coupling when the locking member is in its locking position. The male coupling further includes a locking sleeve disposed about and axially movable with respect to the body between first and second positions. After insertion of the male coupling into the female coupling and upon movement of the locking sleeve to its first position, the locking sleeve forces the locking member to move to its locking position causing the retaining formation of the locking member to engage the internal threads of the female coupling, thereby locking the male coupling and the female coupling together.
Patent AU-2008236316-B2 (AU)
Title: Polynucleotides, polypeptides and methods for increasing oil content, growth rate and biomass of plants
Inventor: RONEN GIL
IPC: C12P7/64
Filed: 2008-04-09
Granted: 2013-05-02
Abstract: Provided are method of increasing oil content, growth rate, biomass, yield and/or vigor of a plant. The methods are effected by upregulating in the plant an expression level of a polypeptide comprising an amino acid sequence at least 90 % homologous to the amino acid sequence selected from the group consisting of SEQ ID NOs: 199, 166-198, 200-221, 229-307, 311-330, 351-353, 355-361, 363-364, 366-368, 218, 222-228, 308-310, 350, 354, 362, 365, 523-649, 786-920, 1047 and 1048. Also provided are polynucleotides, nucleic acid constructs, polypeptides and transgenic plants expressing same which can be used to increase oil content, growth rate, biomass, yield and/or vigor of a plant and produce oil.
Patent AU-2008247404-B2 (AU)
Title: System and method for enhanced gaming platform interactions
Inventor: LUBE ROBERT R
IPC: A63F13/00
Filed: 2008-05-05
Granted: 2012-07-05
Abstract: A gaming console configured with picture-in-picture (PIP) capability for use to gain entry into a group level or competitive level of play. The PIP window is used to form teams or provide information related to group play. The PIP screen may also be used to make request for special services such as making hotel or restaurant reservations, advanced request for getting a car from the concierge, and may also be used to send information about the location of the game console being used by a player so that others may know where the player is currently located.
Patent AU-2008262595-B2 (AU)
Title: An energy supplying device
Inventor: JILKEN LEIF ANDERS
IPC: F24S10/70
Filed: 2008-06-11
Granted: 2014-05-29
Abstract: The invention relates to an energy supplying device intended to be used for energy collection, energy transfer and energy release, but also for cooling and storing energy, which energy supplier (1) has at least one elongated cavity (2), produced by the extrusion of at least one profile (3) in a direction of extrusion (4) by means of at least one tool, said cavity (2) provides space for at least one medium (17), such as air or fluid, to circulate or be stored in the energy supplier (1). Said cavity (2) is enclosed by at least one formation (5) constituting, for example, a wall, floor or roof formation, said formation (5) constitutes at least part of an actively supporting structure (6), for direct or indirect mechanical support of loads, whilst at the same time forming at least one part of a structural element (7), for example to form a house roof, a wall, a board, a bridge, a pier, a road, a pavement, a terrace or balcony, said actively supporting structure (6), which statically has a predetermined wall thickness, and which is the strongest part of the energy supplier (1) for supporting the load directed principally transversely to the direction of extrusion (4), comprises, in an imaginary section transverse to the direction of extrusion (4), at least one beam formation (8), which is statically dimensioned to resist predetermined loads and is constructed, for example, as an I-, L-, O-, T-, U-, V-, X-, Y- or Z-beam.
Patent AU-2008275616-B2 (AU)
Title: Continuous methods for treating liquids and manufacturing certain constituents (e.g., nanoparticles) in liquids, apparatuses and nanoparticles and nanoparticle/liquid solution(s) resulting therefrom
Inventor: PIERCE DAVID K
IPC: B82B3/00
Filed: 2008-07-11
Granted: 2014-07-10
Abstract: Methods and devices for the continuous manufacture of nanopεrticles, microparticles and nanoparticle/liquid solution(s) are disclosed. The nanoparticles (and/or micron-sized particles) comprise a variety of possible compositions, sizes and shapes. The particles (e. g., nanoparticles) are caused to be present (e g, created) in a liquid (e. g., water) by utilizing at least one adjustable plasma (e. g., created by at least one AC and/or DC power source), which plasma communicates with at least a portion of a surface of the liquid. The continuous process causes at least one liquid to flow into, through and out of at least one trough member, such liquid being processed, conditioned and/or effected in said trough member(s).
Patent AU-2008279001-B2 (AU)
Title: Transactional graph-based computation with error handling
Inventor: WHOLEY III JOSEPH SKEFFINGTON
IPC: G06F12/00
Filed: 2008-07-25
Granted: 2014-02-06
Abstract: Processing transactions using graph-based computations includes determining (305) that at least one of a plurality of graph elements of a computation graph of a set of one or more computation graphs includes a computation to be performed for a given transaction, associating the given transaction with an instance (310) of the computation graph that includes reusable computation elements associated with respective graph elements, and executing (320) the graph to perform the computation.